ALS Platform Trial Case Study
How did this first-of-its-kind platform trial tackle ALS's debilitating disease progression and what can other rare disease study teams learn from it?
Effective Data Analysis for Nontraditional Study Designs
Firma's Dr. D.J. Tang shares in a Clinical Researcher article insights on effective data analysis for nontraditional study designs.
Global Clinical Trials and In-Home Visits: Preventing Common Pitfalls
More and more global clinical trials are using a hybrid approach to study visits. Find out the biggest challenges--and how to solve them.
6 Common Questions Clinical Research Teams Have About Home Trial Services
What sites and study teams really want to know about using remote, in-home visits as part of their clinical trial protocols. The answers to the most common questions.
Multi-national studies call for informed approach: Firma Clinical Research
Nikki Skirvin was interviewed by Jenni Spinner about multi-national studies in an article for Outsourcing Pharma earlier this year.
Achieving Clinically Meaningful Treatment Efficacy Summaries: A COVID-19 Case Study
In a recent study, researchers looked at two randomized comparative trials evaluating COVID-19 treatments and outlined the problematic gaps created by the use of the Kaplan-Meier method and hazard ratio.
Real-World Data Use in Clinical Trials Can Yield Real Benefits
Firma’s Dr. D.J. Tang shares in an Outsourcing-Pharma article why RWD can be useful in drug research and development.
FIRMA COMMENCES SCIENTIFIC ADVISORY BOARD
Firma Clinical recently commenced a Scientific Advisory Board for its clinical services, including biometrics/data.
In-Home Services Boost Patient Centricity
In Outsourcing-Pharma, Melissa Nezos, explains how the pandemic increased the need to bring the study to the patient.
Patient-Centric Tools for Today and Tomorrow’s Clinical Trials
Firma’s Melissa Nezos shares in an Applied Clinical Trials article the important role of home visits in hybrid and decentralized/virtual clinical trials.
